Moreover, down-regulation of SIRT3-mediated elevated ROS levels could promote the activation of the steroid receptor coactivator (Src)/focal adhesion kinase (FAK) signaling pathway to enhance cancer metastasis (85). This evidence concerns the gene PTK2 and cancer.